Comparative Analysis of Patient Package Inserts of Local and Imported Anti-Infective Agents in Palestine

Abstract

Background and ObjectiveThe patient package insert is an important source of drug information. The aim of this study was to evaluate and compare the PPI of the anti-infective agents manufactured in Palestine with the imported equivalents.MethodThe selection criteria generated 15 different anti-infective agents available as 36 locally manufactured products and 15 imported equivalents. The design of the patient package insert was evaluated in terms of the number of words used in eight main headings and the presence or absence of certain information regarding nine statements.ResultsInserts of locally manufactured products have significantly fewer words than those of imported products with respect to warnings, dosage and administration, and side effects. The most significant difference was found in the warnings. Moreover, differences were found between inserts of local and imported products in terms of the presence of the nine informative statements. Locally manufactured products did not mention inactive ingredients, clinical pharmacology or date of last revision, but all of them provided information on the use of the drug during pregnancy and lactation and on the duration of therapy. However, in general they provided less information than the imported equivalents.ConclusionPalestinian authorities and local manufacturers should implement appropriate measures to regulate the quality and quantity of information in the patient package insert of locally produced anti-infective agents. PPI improvement will better direct health practices to the benefit of the patients.

Pharmaceuticals companies' promotional brochures: do they display reliable and useful medications' information?

“…Other researchers had, quite often, reported similar differences between the promotional printed materials of the multinationals and branded generics, albeit those differences might not be significant. 20,25,26 This may further confirm our proposal that the quality of scientific medication information provided in pharmaceutical company's brochures screened, of both the multinational and the branded generic pharmaceutical companies, did not provide adequate balanced and reliable medication information, which might even be misleading. 18,27,28 They, as well, were not exactly matching to WHO ethical criteria for medicinal drug promotion.…”

Analysis of Package Inserts of Drugs Utilized in a Tertiary Care Hospital

“…Full prescribing information is submitted by the pharmaceutical companies as a part of the new drug application for marketing to the regulatory authorities. 7 Once the application is approved, the information is accompanied with the drug in the drug cartons. In India, the regulations for manufacture, distribution and sale of pharmaceutical products are present in Section 6 of Schedule D (II) of the Rules which relates to labelling, listing the headings according to which information should be provided in the package inserts.…”

Inhaler Technique Training and Health-Care Professionals: Effective Long-Term Solution for a Current Problem

“…Written information such as medication inserts is not enough, and may convey limited and incomplete information. 38,39 In addition, the acquisition of knowledge alone does not necessarily translate into effective self-management behaviors 40 ; physical demonstration of technique with follow-up assessment and education is essential. 3 Hence, we integrated hands-on education for HCPs into the workshop following the "train the trainer" approach; this is essential for HCPs to develop their own skills, so they can in turn educate patients to insure effective self-management behaviors.…”